 | Up a level |
Schandelmaier, S; Conen, K; von Elm, E; You, J J; Blümle, A; Tomonaga, Y; Saccilotto, R; Amstutz, A; Bengough, T; Meerpohl, J J; Stegert, M; Olu, K K; Tikkinen, K A O; Neumann, I; Carrasco-Labra, A; Faulhaber, M; Mulla, S M; Mertz, D; Akl, E A; Sun, X; ... (2015). Planning and reporting of quality-of-life outcomes in cancer trials. Annals of oncology, 26(9), pp. 1966-1973. Oxford University Press 10.1093/annonc/mdv283
Beldi, G; Enjyoji, K; Wu, Y; Miller, L; Banz, Y; Sun, X; Robson, S.C. (2008). The role of purinergic signaling in the liver and in transplantation: effects of extracellular nucleotides on hepatic graft vascular injury, rejection and metabolism. Frontiers in bioscience - Landmark edition, 13(13), p. 2588. Irvine, Calif.: Frontiers in Bioscience 10.2741/2868
Beldi, G; Wu, Y; Sun, X; Imai, M; Enjyoji, K; Csizmadia, E; Candinas, D; Erb, L; Robson, S.C. (2008). Regulated catalysis of extracellular nucleotides by vascular CD39/ENTPD1 is required for liver regeneration. Gastroenterology, 135(5), pp. 1751-60. Philadelphia, Pa.: Elsevier 10.1053/j.gastro.2008.07.025
